The FDA sent this letter shortly before the agencys April 30 proposal to exclude three weight loss drugs, including tirzepatide, from the 503B bulks list, finding no clinical need for outsourcing facilities to compound these drugs from bulk substances. ProRx and, reportedly, BPI Labs ceased producing these drugs in April, while Medisource stopped in March after its parent company, Hims, decided to cease sales of compounded semaglutide
The strongest signals keep clustering around skin, healing, hair, inflammation, and broader anti-aging support
We'll confirm you're a candidate, walk you through what to expect, and select the medication and dose that fits your goals
C.ChronopoulouE.LabrouN
But you dont actually have to take a separate vitamin C because the topical glutathione product also has topical vitamin C in it already
"It's important to know that prior suggestions that the drug might trigger suicidal thoughts is not borne out in this very large and diverse population in the U.S."